Ascvd - Study guides, Class notes & Summaries

what are major risk factors for ascvd FLASH D family history, low hdl (lessthan 50 and 40), age greater than 45 and 55, smoking, hypertension, dm what diseases are characterized as clinical ascvd? chd, cerebrovd, pad what is dyslipidemia? hdl less than 40 what is hyperldl? ldl greater than 100 what is hypertg tg greager than 150 according to NLA guidelines, what LDL is considered very high? greater than or equal to 190 accordingot NLA guidelines what TG is considered very high? greater tha...

Primary Prevention Treat to minimize risk of first occurrence of atherosclerotic cardiovascular disease (ASCVD) Secondary Prevention •Treat to minimize risk of recurrent ASCVD -Coronary heart disease (e.g., myocardial infarction, angina) -Cerebrovascular disease (e.g., ischemic stroke) -Peripheral arterial disease Take-Home Messages 1.Promote a healthy lifestyle 2.Team-based care; evaluate social determinants of health 3.40-75 yr: calculate 10-yr ASCVD risk; clinician-patient risk discussion...

In patients with T2DM w/ ASCVD, the risk of CHD and ischemic stroke are _____ x greater than in those w/o DM 4 Pharmacologic recommendations for managing patients with ASCVD in T2DM? 1) ADA recommends ________ aspirin (____-____) in pts w/ ASCVD 2) _______ intensity statin for all DM who are ______ yo 3) Manage other comorbid conditions (_____/____) low dose 75-162 mg moderate >40 HTN/ HLD Diabetes is a risk factor for ASCVD but it is thought to be __________ instead of _________. syne...

Identify the primary intervention that is recommended for metabolic syndrome that also serves as the foundation of ASCVD risk reduction. Lifestyle therapy (heart healthy lifestyle) Recognize the statin benefit groups. 1. In patients with clinical ASCVD, reduce low density lipoprotein cholesterol (LDL-C) with _________ therapy or ________ therapy. The more LDL-C is reduced on statin therapy, the greater will be subsequent ______. Use a maximally tolerated statin to lower LDL-C levels by ≥50%....

ASCVD Diseases Dosing 2024/2025 UFH - medically ill - 5000 sc q8-12 h LMWH - medically ill - 40 mg sc qd CrCl<30 = 30 mg qd sc Rivaroxaban - medically ill - 10 mg qd for 35 days UFH - orthopedic surgery - 5000 sc q 8-12h LMWH - orthopedic surgery - 40 mg qd or 30 mg BID Rivaroxaban - orthopedic surgery - 10 mg qd Apixaban - orthopedic surgery - 2.5 mg BID Aspirin - orthopedic surgery - 81-162 mg qd UFH - acute VTE - 80 units/kg bolus, 18 unit/g/hr IV drip LMWH - acute VTE - 1 mg/k...

FNP 571 Final Exam 2023/24- University of Texas, Arlington All of the following statements are correct EXCEPT? 1. 1) Liraglutide (Saxendra) is a GLP-1 receptor agonist 2. 2) Injection of insulin promotes weight loss 3. 3) Contrave (Naltrexone/bupropion extended release) is a weight loss drug 4. 4) Phentermine hydrochloride (Adipex-P, Lomaira) can be prescribed for up to 12 weeks 2. Macy is a 45-year-old female with IBD and is in to see the APRN for a current exacerbation. All of the fo...

Step 1 of patient assessment Do they have ASCVD? -What is their score? -Do they have risk enhancers? What is the next step if the patient does have ASCVD? -If yes we try to prevent future incidences and decide if the patient is moderate or at a high risk What is the next step if the patient doesn't have ASCVD? -If No we do primary prevention and look at: -Age -LDL levels -Do they have Diabetes? What is considered ASCVD? -MI (myocardial Infraction) -ACS (acute coronary syndrome) -Stable/Unsta...

What is ASCVD? 1. Acute coronary syndromes - MI - Unstable angina - Coronary or other arterial revascularization 2. Stable angina 3. Stroke or transient ischemic attack (TIA) 4. Peripheral arterialdsease (PAD) - aotic aneurysm Risk factors for atherosclerosis 1. Dyslipidemia (LDL and lipoprotein abnormalities) 2. Type 2 diabetes (dysglycemia) 3. Hypertension 4. Lifestyle choices (smoking, diet, inactivity, obesity) 5. Age (males >45, females >55) 6. Family history (premature ASCVD males&l...

Altace Ramipril ACEI (block conversion AngI to AngII, block degradation of bradykinin, which is thought to contribute to vasodilatory effects and side effects of dry hacking cough and angioedema) C/I: hx of angioedema, do not use w/in 36 hrs of sacubitril/valsartan (Entresto), do not use with aliskiren in DM Boxed warning: can cause injury and death to the developing fetus when used in 2nd and 3rd trimester. Discontinue as soon as pregnancy is detected Warnings: angioedema, hyperkalemia, hypoten...